In our previous study, sulfated madanin-1, a thrombin inhibitor, significantly repressed the thrombin-induced switch from E-cadherin to N-cadherin, indicating that madanin-1 2S could have a therapeutic effect on cancer cell metastasis [13]. Here, CDH2 is linked to cancer.